Main Menu

Publications Highlights View all by category

Types of Publications


Journal Articles

Sud, A., Morilla, R., Ethell, M., Taussig, D. & Liapis, K. (2015). Green-grey crystals in acute myeloid leukaemia. British journal of haematology, Vol.168 (5), pp. 618-618.

Miraki-Moud, F., Ghazaly, E., Ariza-McNaughton, L., Hodby, K.A., Clear, A., Anjos-Afonso, F., Liapis, K., Grantham, M., Sohrabi, F., Cavenagh, J., et al. (2015). Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo. Blood, Vol.125 (26), pp. 4060-4068.  show abstract

Liapis, K., Taussig, D., Cotter, F.E. & Gribben, J.G. (2014). Cutaneous cryptococcosis in Hodgkin lymphoma. British journal of haematology, Vol.164 (4), pp. 467-467.

Griessinger, E., Anjos-Afonso, F., Pizzitola, I., Rouault-Pierre, K., Vargaftig, J., Taussig, D., Gribben, J., Lassailly, F. & Bonnet, D. (2014). A Niche-Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia-Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self-Renewal Mechanisms. Stem cells translational medicine, Vol.3 (4), pp. 520-529.

Liapis, K., Chung, Y., Akhtar, W. & Taussig, D. (2014). A patient with rheumatoid arthritis, cryoglobulinaemia, and an "accidental" finding. Bmj, Vol.348 (apr14 3), pp. g2701-g2701.

Manodoro, F., Marzec, J., Chaplin, T., Miraki-Moud, F., Moravcsik, E., Jovanovic, J.V., Wang, J., Iqbal, S., Taussig, D., Grimwade, D., et al. (2014). Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia. Blood, Vol.123 (13), pp. 2066-2074.  show abstract

Davies, J.K., Taussig, D., Oakervee, H., Smith, M., Agrawal, S., Cavenagh, J.D. & Gribben, J.G. (2013). Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion. British journal of haematology, Vol.162 (4), pp. 525-529.

Anjos-Afonso, F., Currie, E., Palmer, H.G., Foster, K.E., Taussig, D.C. & Bonnet, D. (2013). CD34− Cells at the Apex of the Human Hematopoietic Stem Cell Hierarchy Have Distinctive Cellular and Molecular Signatures. Cell stem cell, Vol.13 (2), pp. 161-174.

Rouault-Pierre, K., Lopez-Onieva, L., Foster, K., Anjos-Afonso, F., Lamrissi-Garcia, I., Serrano-Sanchez, M., Mitter, R., Ivanovic, Z., de Verneuil, H., Gribben, J., et al. (2013). HIF-2α Protects Human Hematopoietic Stem/Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress. Cell stem cell, Vol.13 (5), pp. 549-563.

Miraki-Moud, F., Anjos-Afonso, F., Hodby, K.A., Griessinger, E., Rosignoli, G., Lillington, D., Jia, L., Davies, J.K., Cavenagh, J., Smith, M., et al. (2013). Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proceedings of the national academy of sciences, Vol.110 (33), pp. 13576-13581.

Vargaftig, J., Taussig, D.C., Griessinger, E., Anjos-Afonso, F., Lister, T.A., Cavenagh, J., Oakervee, H., Gribben, J. & Bonnet, D. (2012). Frequency of leukemic initiating cells does not depend on the xenotransplantation model used. Leukemia, Vol.26 (4), pp. 858-860.

Joshi, N.M., Hassan, S., Jasani, P., Dixon, S., Cavenagh, J.D., Oakervee, H.E., Smith, M., Agrawal, S.A., Auer, R., de Vos, J., et al. (2012). Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract. British journal of haematology, Vol.157 (3), pp. 403-407.

Auer, R.L., MacDougall, F., Oakervee, H.E., Taussig, D., Davies, J.K., Syndercombe-Court, D., Agrawal, S., Cavenagh, J.D., Lister, T.A. & Gribben, J.G., et al. (2012). T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies. British journal of haematology, Vol.157 (5), pp. 580-585.

Farren, T.W., Giustiniani, J., Liu, F.-., Tsitsikas, D.A., Macey, M.G., Cavenagh, J.D., Oakervee, H.E., Taussig, D., Newland, A.C., Calaminici, M., et al. (2011). Differential and tumor-specific expression of CD160 in B-cell malignancies. Blood, Vol.118 (8), pp. 2174-2183.  show abstract

Taussig, D.C., Vargaftig, J., Miraki-Moud, F., Griessinger, E., Sharrock, K., Luke, T., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S.G., et al. (2010). Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction. Blood, Vol.115 (10), pp. 1976-1984.  show abstract

Le Dieu, R., Taussig, D., Lister, T.A. & Gribben, J.G. (2009). Negative immunomagnetic selection of T cells from peripheral blood of presentation AML specimens. Journal of immunological methods, Vol.348 (1-2), pp. 95-100.

Anjos-Afonso, F., Taussig, D. & Bonnet, D. (2009). PERTURBED BONE MARROW MESENCHYMAL STROMAL (MSC) COMPARTMENT IN AML PATIENTS: IMPLICATION FOR UNDERSTANDING LEUKEMIC MICROENVIRONMENT. Experimental hematology, Vol.37 (9), pp. S52-S53.

Le Dieu, R., Taussig, D.C., Ramsay, A.G., Mitter, R., Miraki-Moud, F., Fatah, R., Lee, A.M., Lister, T.A. & Gribben, J.G. (2009). Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood, Vol.114 (18), pp. 3909-3916.  show abstract

Taussig, D.C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D.J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S.G., et al. (2008). Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood, Vol.112 (3), pp. 568-575.  show abstract

Le Dieu, R., Ramsay, A.G., Taussig, D., Mitter, R. & Gribben, J.G. (2008). Differential Gene Expression Profile Identifies the Nature of T Cell Defects in AML Patients at Diagnosis. Blood, Vol.112 (11), pp. 433-433.

Pearce, D.J., Taussig, D., Zibara, K., Smith, L.-., Ridler, C.M., Preudhomme, C., Young, B.D., Rohatiner, A.Z., Lister, T.A. & Bonnet, D., et al. (2006). AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood, Vol.107 (3), pp. 1166-1173.  show abstract

Pearce, D., Taussig, D. & Bonnet, D. (2006). Implications of the Expression of Myeloid Markers on Normal and Leukemic Stem Cells. Cell cycle, Vol.5 (3), pp. 271-273.

Davies, J.K., Taussig, D.C., Oakervee, H., Davies, A.J., Agrawal, S.G., Gribben, J.G., Lister, T.A. & Cavenagh, J.D. (2006). Long-Term Follow-Up After Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia/Myelodysplastic Syndrome: Late CNS Relapses Despite Graft-Versus-Host Disease. Journal of clinical oncology, Vol.24 (14), pp. e23-e25.

Pearce, D.J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A.Z., Lister, T.A. & Bonnet, D. (2005). Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples. Stem cells, Vol.23 (6), pp. 752-760.

Taussig, D.C., Pearce, D.J., Simpson, C., Rohatiner, A.Z., Lister, T.A., Kelly, G., Luongo, J.L., Danet-Desnoyers, G.A. & Bonnet, D. (2005). Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood, Vol.106 (13), pp. 4086-4092.  show abstract

TAUSSIG, D. (2003). Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting. J clin oncol, Vol.21, pp. 3060-3065.

Allen, D. (2002). Sternal osteomyelitis caused by Aspergillus fumigatus in a patient with previously treated Hodgkin's disease. Journal of clinical pathology, Vol.55 (8), pp. 616-618.

Longhurst, H.J., Taussig, D., Haque, T., Court, D.S., Cavenagh, J., Edgar, J.D. & Helbert, M.R. (2002). Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome. British journal of haematology, Vol.116 (2), pp. 497-499.

(2002). Male Cells in Female Recipients of Hematopoietic-Cell Transplants. New england journal of medicine, Vol.347 (3), pp. 218-220.

(1997). Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery. New england journal of medicine, Vol.336 (20), pp. 1452-1454.


Conferences

Manodoro, F., Marzec, J., Chaplin, T., Miraki-Moud, F., Moravcsik, E., Jovanovic, J.V., Wang, J., Iqbal, S., Taussig, D., Grimwade, D., et al. (2014). Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukaemia, BRITISH JOURNAL OF HAEMATOLOGY, Vol.165, p.16.

Jasani, P.D., MacDougall, F., Smith, M.L., Cavenagh, J.D., Lister, T.A., Gribben, J.G., Taussig, D.C. & Oakervee, H.E. (2012). Treatment of acute myeloid leukaemia in the elderly: a retrospective analysis, BRITISH JOURNAL OF HAEMATOLOGY, Vol.157, pp.64-65.

Taussig, D., Miraki-Moud, F., Lister, A., Bonnet, D. & Gribben, J. (2010). BONE MARROW FAILURE IN ACUTE MYELOID LEUKEMIA IS INDUCED BY A BLOCK IN DIFFERENTIATION OF NORMAL HEMATOPOIETIC STEM CELLS, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Vol.95, p.13.

Ghazaly, E., Smith, P., Quentmeier, H., Drexler, H., Iqbal, S., Taussig, D., Young, B., Lister, A., Joel, S. & Fitzgibbon, J., et al. (2010). ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Vol.95, p.20.

Mannari, D., Jasani, P., MacDougall, F., Taussig, D. & Cavenagh, J. (2010). ALLOGENEIC HAEMOPOIETIC STEM-CELL TRANSPLANTATION USING A NON T-CELL DEPLETE REDUCED INTENSITY CONDITIONING PROTOCOL FOR ACUTE MYELOID LEUKAEMIA & MYELODYSPLASIA: A 10-YEAR SINGLE CENTRE EXPERIENCE, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Vol.95, p.275.

Le Dieu, R., Taussig, D., MacDougal, F., Lister, A. & Gribben, J.G. (2007). CD3+/CD56+cells, but not natural killer T cells, are increased in peripheral blood of untreated patients with leukemia, BLOOD, Vol.110 (11), p.538A.

Zibara, K., Pearce, D., Taussig, D., Bureau, E., Skoulakis, S., Tomlinson, S. & Young, B. (2005). Gene expression profiling reveals fundamental differences between leukemic stem cells (Lin-CD34+CD38-) and mature blasts (Lin-CD34+CD38+) of acute myeloid leukaemia (AML) patients, EXPERIMENTAL HEMATOLOGY, Vol.33 (7), p.83.

Zibara, K., Pearce, D., Taussig, D., Skoulakis, S., Tomlinson, S., Bureau, E., Young, B.D. & Bonnet, D. (2005). Gene expression profiling reveals fundamental differences between leukemic stem cells (Lin-CD34+CD38-) and mature blasts (Lin-CD34+CD38+) of acute myeloid leukaemia (AML) patients., BLOOD, Vol.106 (11), p.399A.

Pearce, D.J., Taussig, D., Simpson, C. & Bonnet, D. (2004). A high ALDH activity identifies both normal and leukemic stem cells, BLOOD, Vol.104 (11), p.199B.

Taussig, D., Pearce, D.J., Simpson, C., Rohatiner, A., Lister, T.A. & Bonnet, D. (2003). Acute myeloid leukaemia stem cells express the CD33 antigen., BLOOD, Vol.102 (11), p.143B.

Pearce, D., Taussig, D., Rohatiner, A. & Bonnet, D. (2002). Comparison of AML engraftment in murine NOD/SCID and beta 2m-/-, NOD/SCID xenotransplantation assays., BLOOD, Vol.100 (11), p.555A.

In this section

Research overview Publications